首页 | 本学科首页   官方微博 | 高级检索  
检索        

捷佰舒联合放疗治疗晚期食管癌的近期疗效观察
引用本文:丁兆军,隋世华,陈为志,迟玉华.捷佰舒联合放疗治疗晚期食管癌的近期疗效观察[J].实用肿瘤学杂志,2004,18(4):258-260.
作者姓名:丁兆军  隋世华  陈为志  迟玉华
作者单位:山东省日照市人民医院肿瘤科,日照,276826
摘    要:目的捷佰舒(注射用奈达铂)联合放疗治疗晚期食管癌的近期疗效和毒副作用.方法51例病人分为试验组和对照组,试验组患者接受捷佰舒化疗联合放疗,对照组患者接受放疗,对比观察两组病人的治疗疗效和毒性反应,作统计学分析.结果试验组有效率达到81.8%,对照组有效率为55.6%,两组对比有差别.结论捷佰舒联合放疗可以有效的治疗晚期食管癌,毒副作用较小,因而是安全有效的,可以在临床上进一步观察和研究.

关 键 词:捷佰舒  化疗  放疗  食管癌
修稿时间:2004年7月8日

The short period observation of advanced esophageal cancer treated with nedaplatin chemotherapy and radiotherapy
DING Zhaojun,SUI Shihua,CHEN Weizhi,CHI Yuhua The.The short period observation of advanced esophageal cancer treated with nedaplatin chemotherapy and radiotherapy[J].Journal of Practical Oncology,2004,18(4):258-260.
Authors:DING Zhaojun  SUI Shihua  CHEN Weizhi  CHI Yuhua The
Institution:DING Zhaojun,SUI Shihua,CHEN Weizhi,CHI Yuhua The Department of Oncology,The People's Hospital of Rizhao 276800
Abstract:Objective To study the short-period therapy effect and side effect of advanced esophageal cancer treated with nedaplatin chemotherapy and radiotherapy. Methods 51 patients were divided into trail group and control group accepted radiotherapy only. The two groups were observed for the short-period therapy effect and side effect. Results The effective rates of the trail group and the control group were 81.8% and 55.6% respectively, which proved to be distinct, but the side effect of two groups was similar. Conclusion Nedaplatin chemotherapy and radiotherapy can effectively treat advanced esophageal cancer with less side effect.
Keywords:Nedaplatin  Chemotherapy  Radiotherapy  Esophageal cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号